MRGRX
Price
$60.45
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

MRGRX vs VTSAX

Header iconMRGRX vs VTSAX Comparison
Open Charts MRGRX vs VTSAXBanner chart's image
MFS Core Equity I
Price$60.45
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
MRGRX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRGRX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRGRX is a StrongBuy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. MRGRX (7B). VTSAX pays higher dividends than MRGRX: VTSAX (1.35) vs MRGRX (0.66). MRGRX was incepted earlier than VTSAX: MRGRX (28 years) vs VTSAX (24 years). MRGRX is a more actively managed with annual turnover of: 35.00 vs. VTSAX (2.00). MRGRX has a lower initial minimum investment than VTSAX: MRGRX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. MRGRX (30.03). VTSAX return over 5 years is better than : 87.46 vs. MRGRX (71.64).
MRGRXVTSAXMRGRX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years24 years-
Gain YTD23.74624.89195%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets7B1.73T0%
Annual Yield % from dividends0.661.3549%
Returns for 1 year30.0333.3990%
Returns for 3 years13.5822.8260%
Returns for 5 years71.6487.4682%
Returns for 10 years106.79194.0755%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals